Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass?

Abstract

Cardiopulmonary bypass (CPB) is associated with an accumulation of total body water and a systemic inflammatory response syndrome (SIRS), which, in turn, is associated with organ dysfunction and postoperative morbidity. It has been suggested that modified ultrafiltration (MUF) may be capable of reducing SIRS and improving clinical outcome by filtering out the inflammatory mediators generated during CPB. This paper reviews the data regarding the use of MUF in paediatric and adult settings. Specifically, three issues will be considered: 1) Does MUF improve clinical outcome? 2) Does MUF reduce the systemic inflammatory response to cardiac surgery with CPB? 3) Is MUF more effective than conventional ultrafiltration in improving clinical outcome?

Get full access to this article

View all access options for this article.

References

Naik S

Knight A

Elliott MJ.

A successful modification of ultrafiltration for cardiopulmonary bypass. Perfusion1991; 6: 41-50.

Naik S

Elliott MJ.

Ultrafiltration and paediatric cardiopulmonary bypass. Perfusion1993; 8: 101-112.

Skaryak LA

Kirshbom PM

DiBernardo LR

et al.

Modified ultrafiltration improves cerebral metabolic recovery after circulatory arrest. J Thorac Cardiovasc Surg1995; 109: 744-752.

Wang MJ

Chiu IS

Hsu CM

et al.

Efficacy of ultra-filtration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg1996; 61: 651-656.

Draasima AM

Hazekamp MG

Frank M

et al.

Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery. Ann Thorac Surg1997; 64: 521-525.

Wang W

Huang H

Zhu D

et al.

Modified ultrafiltration in paediatric cardiopulmonary bypass. Perfusion1998; 13: 304-310.

Davies MJ

Nguyen K

Gaynor J

et al.

Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg1998; 115: 361-370.

Bando K

Turrentine MW

Vijay P

et al.

Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg1998; 66: 821-828.

Daggett CW

Lodge AJ

Scarborough JE

et al.

Modified ultrafiltration versus conventional ultrafiltration: a randomized prospective study in neonatal piglets. J Thorac Cardiovasc Surg1998; 115: 336-342.

10.

Pearl JM

Manning PB

McNamara JL

et al.

Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, endothelin-1 in infants undergoing cardiopulmonary bypass. Ann Thorac Surg1999; 68: 1369-1375.

11.

Yndgaard S

Andersen LW

Andersen C

et al.

The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardio-pulmonary bypass. J Cardiothorac Vasc Anesth2000; 14: 399-401.

12.

Onoe M

Oku H

Kitayama H

et al.

Modified ultra-filtration may improve postoperative pulmonary function in children with a ventricular septal defect. Surg Today2001; 31: 586-590.

13.

Ootaki Y

Yamaguchi M

Oshima Y

et al.

Effects of modified ultrafiltration on coagulation factors in pediatric cardiac surgery. Surg Today2002; 32: 203-206.

14.

Friesen RH

Campbell DN

Clarke DR

et al.

Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open heart operations. Ann Thorac Surg1997; 64: 1787-1789.

15.

Chew MS

Brix-Christensen V

Ravn HB

et al.

Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective randomized study. Perfusion2002; 17: 327-333.

16.

Maluf MA.

Modified ultrafiltration in surgical correction of congenital heart disease. Perfusion2003; 18: 61-68.

17.

Tassani P

Richter JA

Eising G

et al.

Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. J Cardiothorac Vasc Anesth1999; 13: 285-291.

18.

Boga M

Islamoglu F

Badak I

et al.

The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting. Perfusion2000; 15: 143-150.

19.

Grunenfelder J

Sund G

Schoeberlein A

et al.

Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac Surg2000; 17: 77-83.

20.

Leyh RG

Bartels C

Joubert-Hubner E

et al.

Influence of modified ultrafiltration on coagulation, fibrinolysis and blood loss in adult cardiac surgery. Eur J Cardiothorac Surg2001; 19: 145-151.

21.

Luciani GB

Menon T

Vecchi B

et al.

Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial. Circulation2001; 104: I253-I259.

22.

Keziltepe U

Uysalel A

Corapcioglu T

et al.

Effects of conventional and modified ultrafiltration in adult patients. Ann Thorac Surg2001; 71: 684-693.

23.

Thompson LD

McElhinney DB

Findlay P

et al.

A prospective randomized study comparing volume standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg2001; 122: 220-228.

24.

Journois D

Israel-Biet D

Pouard P

et al.

High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology1996; 85: 965-976.